Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 29th April 2022, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 27,788,174 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Interim Report Q1 – January – March, 2022 Redsense Medical AB (publ)

January – March 2022 · Net sales amounted to kSEK 3,127 (685), an increase by 356 percent. · Operating loss, EBIT amounted to kSEK 2,076 (3,150). · Result after tax amounted to kSEK -1,549 (-1,489). · Earnings per share was SEK -0.11(-0.11) before and after dilution. Significant events during the period · On March 14, Redsense Medical successfully participated in a virtual briefing about venous needle dislodgement (VND) for US congress together with multiple professional renal organizations and advocacy associations. · On March 15, Redsense Medical announced that

Biosergen is preparing a Phase II study of BSG005 against Mucormycosis, the Black Fungus.

May 2, 2022: Biosergen today announced that it is preparing a Phase II clinical trial of BSG005 against Mucormycosis, otherwise known as the Black Fungus. Mucormycosis is a difficult to treat fungal infection with high mortality.As novel fungicidal polyene antifungal product BSG005 is well positioned to provide a broad single product treatment alternative for life threatening, difficult to treat, resistant, invasive fungal infections. Different to other polyene products, such as Amphotericin B or Ambisome, BSG005 is without any signs of nephrotoxicity. To support this unique product profile,

Caverion acquires the business of Kaldt og Varmt AS, a heating and cooling specialist in Norway

Caverion Corporation Investor news 2 May 2022 at 9.15 a.m. EESTCaverion acquires the business of Kaldt og Varmt AS, a heating and cooling specialist in Norway Caverion has closed an agreement to acquire the business of Kaldt og Varmt AS (“Kaldt og Varmt”) in Norway. Kaldt og Varmt is a heating and cooling specialist based in Askim, Norway. The acquisition complements Caverion’s service offering in the region. Kaldt og Varmt operates in the Oslo area and its eastern surroundings. Since its establishment in 2016, the company has grown to be a solid player in the industry that also

XNK Therapeutics gets abstract on ACP-001 selected for presentation at EHA2022

XNK Therapeutics AB (“XNK”) today announced that an abstract on the long-term follow-up of the Phase I/II clinical trial study ACP-001 with its leading candidate drug has been selected for a presentation at European Hematology Association’s hybrid conference EHA2022, which is held in Vienna, Austria, on June 9[th]-12[th].The abstract, titled Autologous NK Cells as Consolidation After Front-Line Stem Cell Transplantation in Multiple Myeloma: A Long-Term Follow-Up, will be presented by the first author Johan Lund at a poster session on Friday, June 10, 16:30 - 17:45 CEST. The other authors

Invitation to Embracer Group’s presentation on its acquisition of Eidos, Crystal Dynamics and Square Enix Montréal at 09.00 (CEST)

Embracer Group hereby invites you to a presentation on today’s press release and announcement of the acquisition of Eidos, Crystal Dynamics and Square Enix Montréal amongst other assets.The presentation will be held in English by CEO Lars Wingefors together with Phil Rogers, CEO Square Enix America and Europe, Scot Amos, Studio Head Crystal Dynamics, David Anfossi, Studio Head Eidos Montréal and Patrick Naud, Studio Head Square Enix Montréal. A Q&A session will follow the presentation. Date:           May 2, 2022 Time:          09:00 (CEST) Online:        Welcome to participate

Managers’ transactions – Koskinen

Nordea Bank AbpStock exchange release – Managers’ transactions2 May 2022 at 09.00 EET Transaction notification under Article 19 of the EU Market Abuse Regulation Person subject to the notification requirementName: KOSKINEN, JUSSIPosition: OTHER SENIOR MANAGERIssuer: Nordea Bank AbpLEI: 529900ODI3047E2LIV03 Notification type: INITIAL NOTIFICATIONReference number: 13750/11/8 Transaction date: 2022-04-29Venue: XHELInstrument type: SHAREISIN: FI4000297767Nature of the transaction: Acquisition Transaction details(1): Volume: 1,000 Unit price: 9.45300 EUR

Managers’ transactions – Vang-Jensen

Nordea Bank AbpStock exchange release – Managers’ transactions2 May 2022 at 09.00 EET Transaction notification under Article 19 of the EU Market Abuse Regulation Person subject to the notification requirementName: VANG-JENSEN, FRANKPosition: CHIEF EXECUTIVE OFFICERIssuer: Nordea Bank AbpLEI: 529900ODI3047E2LIV03 Notification type: INITIAL NOTIFICATIONReference number: 13719/12/10 Transaction date: 2022-04-29Venue: XCSEInstrument type: SHAREISIN: FI4000297767Nature of the transaction: Acquisition Transaction details(1): Volume: 13  Unit price: 71.62000

AcadeMedia publishes the Nomination Committee for the AGM 2022

In accordance with the principles adopted by the Annual General Meeting 2020, the nomination committee shall comprise one representative for each of the three largest shareholders based on ownership of the company as per the end of the financial year’s third quarter. The chairman of the board shall be a co-opted member (Sw. adjungerad). The Nomination Committee for the Annual General Meeting on 30 November 2022 consists of:Rune Andersson, Mellby GårdMats J. Andersson, Nordea FonderJoachim Spetz, Swedbank Robur Fonder For more informationhttps://academedia.se/en/investors/

One of the Nordic region’s leading financial software companies presents the best financial result since new ownership

Vitec Aloc, one of the Nordic region’s leading companies within capital market software, is ready with its financial statement for 2021. Profits are the highest since the new strategic ownership, and the bottom line reflects increasing growth. The main reason for this is the implementation of a new business model and the continuous work on professionalisation and focus on quality.The Danish provider of investment management solutions to some of the largest banks, asset managers, family offices and pension and insurance companies in Scandinavia, Vitec Aloc, can today present pre-tax profits

Concentric AB announces a restatement of segmental reporting

Following the acquisition of EMP and an internal organisation and reporting review, the Board of Directors has decided Concentric AB will report by technology segments, namely Engines and Hydraulics, rather than geographical regions, which is consistent with both how the business will be managed and reported internally in the future. The Engine division will include all Concentric, Licos and EMP branded engine products, including royalties and net income from our joint venture, Alfdex. The Hydraulics division will include Concentric and Allied branded hydraulic products. This change is

Invitation to the presentation of SLP’s results for January–March 2022

Swedish Logistic Property AB (“SLP”) will publish its interim report for the first quarter of 2022 on Wednesday, 4 May 2022, at 08:45 a.m. CEST. The interim report will be presented via a recorded audiocast at 10:00 a.m. on the same day.Peter Strand, CEO, and Tommy Åstrand, CFO, will present the results and operations. The presentation material (images+audio) will be available at: https://slproperty.se/en/ir/reports-and-presentations/ and https://tv.streamfabriken.com/slp-q1-rapport-2022 The presentation will be held in Swedish. Questions can be submitted in writing via email to info@

STENOCARE is ready to start delivery of their THC oil products to Danish patients

STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER:  STENO This is a follow-up from the press release 07.01.2022, that announced STENOCARE had received product approval from the Danish Medicines Agency to have a medical cannabis oil product accepted into the Danish Pilot Programme.Waiting time is over and sales can begin: STENOCARE has now completed the import of the new medical cannabis oil product into Denmark. The product is named THC Olie STENOCARE and is available in 30 mL bottles with a strength of 30 mg/mL THC and <0.1 mg/mL CBD. Dosing is delivered via an oral

Swedish start-up AI Medical Technology initiates clinical study in primary care facilities to validate Dermalyser – an AI-driven support tool for diagnosing malignant melanoma

Stockholm, Sweden, May 2, 2022. On the first day of this year’s Skin Cancer Awareness Month, Swedish Artificial Technology start-up AI Medical Technologies announces the start of a clinical trial at 30 Swedish primary care facilities with Dermalyser, a diagnostic decision support system empowered with advanced artificial intelligence (AI). The study is a prospective, pivotal confirmatory multi-centre, non-interventional clinical investigation with the following aims: 1. Evaluate the clinical safety, performance and benefit of Dermalyser in patients with cutaneous lesions where malignant

Embracer Group enters into an agreement to acquire Eidos, Crystal Dynamics, and Square Enix Montréal amongst other assets

Embracer Group AB (”Embracer”) has entered into an agreement to acquire the development studios Crystal Dynamics, Eidos-Montréal, Square Enix Montréal, and a catalogue of IPs including Tomb Raider, Deus Ex, Thief, Legacy of Kain and more than 50 back-catalogue games from SQUARE ENIX HOLDINGS CO., LTD. (“Square Enix Holdings”). In total, the acquisition includes ~1,100 employees across three studios and eight global locations. The total purchase price amounts to USD 300 million on a cash and debt free basis, to be paid in full at closing. Embracer has secured additional long-term debt funding

Odfjell SE: Harald Fotland appointed new CEO

Odfjell SE’s Board of Directors announces that Harald Fotland has been appointed as the Company's new Chief Executive Officer (CEO). Fotland comes from the position as Odfjell's Chief Operating Officer, and will assume the CEO position on May 6, 2022."We are pleased to have an internal candidate take over the helm at Odfjell. The appointment was made after a process including external and internal candidates. Harald has excelled at leading innovative and transformative projects during his time at the Company. He has the expertise and experience to ensure continuity and progress, and to

Receipt of governmental approvals for the contemplated merger with Lundin Energy’s E&P business

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Aker BP is pleased to announce that it has now received all necessary approvals from the Norwegian Ministry of Petroleum and Energy, the Norwegian Ministry of Finance and the Norwegian Competition Authority, for the completion of the contemplated

Wyld’s share commences trading on the OTCQB market in the United States

Wyld shares begin trading today on the OTCQB Venture Market in the U.S. under the symbol "WYLDF". Joining the OTCQB Venture Market allows over-the-counter trading in Wyld’s ordinary share listed on the Nasdaq First North Growth Market. The purpose is to increase visibility and accessibility in the US capital market thereby providing greater liquidity and value to the company’s shareholders.Joining the OTCQB Venture Market will facilitate US investors to trade in Wyld Networks’ ordinary share in US dollars, with a US ticker symbol, and during US market hours. Wyld Networks’ share remains

Managers’ transactions – Hester

Nordea Bank AbpStock exchange release – Managers’ transactions2 May 2022 at 09.00 EET Transaction notification under Article 19 of the EU Market Abuse Regulation Person subject to the notification requirementName: HESTER, STEPHENPosition: Member of the BoardIssuer: Nordea Bank AbpLEI: 529900ODI3047E2LIV03 Notification type: INITIAL NOTIFICATIONReference number: 13747/9/12 Transaction date: 2022-04-29Venue: CHIXInstrument type: SHAREISIN: FI4000297767Nature of the transaction: Acquisition Transaction details(1): Volume: 20,163 Unit price: 9.56650 EUR

GomSpace (provider of nanosatellites) announces its quarterly results for the first quarter 2022

GomSpace Group AB (the “Company”) announces its interim report for the first quarter of 2022. The report is available on the Company’s homepage (www.gomspace.com). The following is taken from the quarterly report: First quarter summary 1 January – 31 March 2022 (2021) · Order intake increased by 74% to T.SEK 41,497 (23,798) · Net revenues increased by 122% toT.SEK 78,365 (35,245) · Gross margin increased to 32% (3%) · Operating profit (EBIT) increased to T.SEK 4,166 (negative 13,911) · Earnings per share were SEK 0.06 (negative 0.24) Events · In March we have

Nixu and SANS to collaborate: Training of information security experts increases the cyber resilience of organizations in Finland

Nixu Corporation, press release May 2, 2022, at 8:30 a.m. EESTNixu, the European cybersecurity services company, and SANS Institute, the largest global organization providing cybersecurity training and certifications, have joined forces to provide high-quality cybersecurity training to organizations operating in Finland.   Through the collaboration, Nixu aims, in particular, to make topical and high-quality information security training easily available to companies and organizations operating in Finland. The SANS courses and related GIAC certifications are designed to develop

Updated ASCO Guidelines Strongly Recommend Use of the Oncotype DX Breast Recurrence Score[®] Test in Node-Negative and the Majority of Node-Positive Early-Stage Breast Cancer Patients

· Oncotype DX[®] receives highest rating of all multigene tests in the guidelines for quality of evidence and strength of recommendation · New guidelines reflect highest level of evidence from independent RxPONDER study, recently published in The New England Journal of MedicineMADISON, Wis., April 28, 2022 – Exact Sciences Corp. (NASDAQ: EXAS), a global leader in cancer diagnostics, today announced that recommended use of its Oncotype DX Breast Recurrence Score® test in early-stage breast cancer patients has been expanded by the American Society of Clinical Oncology (ASCO) in its 2022

interim report 2022, January to March

stronger rental marketsRental income was EUR 66 million,an increase of 36.6 percent compared to the same period last year.The like-for-like vacancy rate decreased during the first quarter by 0.9 percentage points to 11.6 percent,in line with the ambition to reduce construction related vacancy and increase the cash flow from properties. At the end of March, the market value of the property portfolio was EUR 6,334 million.The value change was EUR 13 million, equivalent to 0.2 percent.Akelius acquired properties for EUR 130 million during the period, in Montreal and Toronto.The

Strong growth and increasing margins start 2022 off

Knowit is starting the year off with net sales growth of 67.6 percent in the first quarter, combined with an adjusted EBITA margin of 11.5 percent. Net sales were SEK 1,695.3 (1,011.4) million and the EBITA profit, adjusted for acquisition and integration costs, was SEK 194.2 (103.3). A strong demand for Knowit’s services, combined with successful deliveries to clients, sets the tone during the first quarter of the year.“It is gratifying to present a first quarter with high growth combined with increasing margins. The integration of the acquisitions performed in recent years has been highly

There are no items matching the current filter
There are no more items matching the current filter
Back to top